Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease (Q34626110)

3 August 2017

1 reference

title

Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease (English)

1 reference

3 August 2017

0 references

1

Paul S Aisen

1 reference

3 August 2017

1 April 2002

1 reference

Journal of Pain and Symptom Management

3 August 2017

1 reference

3 August 2017

23

1 reference

3 August 2017

4 Suppl

1 reference

3 August 2017

S35-40

1 reference

Cytokines in Alzheimer's disease

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

The search for disease-modifying treatment for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Neuroinflammatory signaling upregulation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900374-3

7 January 2021

10.1016/S0885-3924(02)00374-3

Identifiers

DOI

1 reference

release_yzbam6cnevhbljhnqpy4sprxn4

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yzbam6cnevhbljhnqpy4sprxn4

24 November 2022

mapped directly with Wikidata item

PubMed ID

11992749

1 reference

PubMed ID

11992749